EcoDrugPlus

Ensembl ID : ENSODEG00000020382
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000020189
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000020093
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000012512
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSODEG00000011783
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSODEG00000016495
Gene Symbol: -
Cross references: -
328 Possible Orthologues:

Ensembl ID : ENSODEG00000008514
Gene Symbol: -
Cross references: -
328 Possible Orthologues:

Ensembl ID : ENSODEG00000001530
Gene Symbol: -
Cross references: -
290 Possible Orthologues:

Ensembl ID : ENSODEG00000020035
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000019735
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000019345
Gene Symbol: -
Cross references: -
81 Possible Orthologues:

Ensembl ID : ENSODEG00000016036
Gene Symbol: -
Cross references: -
235 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).